•
Sep 30, 2022

Albemarle Q3 2022 Earnings Report

Albemarle's financial performance was marked by a significant increase in net sales and adjusted EBITDA, driven by strong demand for lithium-ion batteries.

Key Takeaways

Albemarle Corporation reported a net sales increase of 152% for the third quarter of 2022, reaching $2.1 billion. The company's adjusted EBITDA increased by 447% to $1.2 billion, and net income attributable to Albemarle Corporation was $897.2 million, or $7.61 per diluted share.

Net sales increased by 152% to $2.1 billion.

Net income was $897.2 million, or $7.61 per diluted share.

Adjusted EBITDA increased by 447% to $1.2 billion.

The company completed the acquisition of the Qinzhou lithium conversion plant in Guangxi China.

Total Revenue
$2.09B
Previous year: $831M
+151.9%
EPS
$7.5
Previous year: $1.05
+614.3%
Adjusted EBITDA
$1.2B
Previous year: $218M
+451.5%
Gross Profit
$1.04B
Previous year: $249M
+318.7%
Cash and Equivalents
$1.38B
Previous year: $595M
+132.4%
Free Cash Flow
$582M
Previous year: -$151M
-485.2%
Total Assets
$13.8B
Previous year: $10.8B
+27.7%

Albemarle

Albemarle

Forward Guidance

Full-year 2022 outlook remains strong, with net sales expected to be more than double and adjusted EBITDA expected to be nearly four times 2021 results.

Positive Outlook

  • Net sales expected to be $7.1 - $7.4 billion
  • Adjusted EBITDA expected to be $3.3 - $3.5 billion
  • Adjusted EBITDA Margin 46% - 47%
  • Adjusted Diluted EPS $19.75 - $21.75
  • Net Cash from Operations $1.45 - $1.65 billion

Challenges Ahead

  • Bromine-related weakness in key end markets, including consumer and industrial electronics and building and construction.
  • Catalysts segment continues to experience natural gas pricing pressure related to the war in Ukraine and rising raw material costs.
  • Potential downside of volume shortfalls (e.g., delays in commissioning and production ramp up at expansion sites and qualifications for tolling) for the remainder of the year
  • Emerging softness in some end markets such as consumer and industrial electronics and building and construction for Bromine
  • Catalysts segment outlook for the full-year 2022 adjusted EBITDA expected to be down 45-65% year over year